Log in
Enquire now

List of Fred Hutchinson Cancer Research Center patents

List of Fred Hutchinson Cancer Research Center patents
List of Sol Chip patents
List of Uster Technologies patents
List of Varentec patents
Companies in the Industrial IoT industry
List of NGOs in Tippecanoe County, Indiana
Patents where
Current Assignee
Name
is
Fred Hutchinson Cancer Research CenterFred Hutchinson Cancer Research Center
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 7399633 Methods for immortalizing cells

Patent 7399633 was granted and assigned to Fred Hutchinson Cancer Research Center on July, 2008 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7399633
July 15, 2008
‌
US Patent 10011871 Compositions and methods for accurately identifying mutations

Patent 10011871 was granted and assigned to Fred Hutchinson Cancer Research Center on July, 2018 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10011871
July 3, 2018
‌
US Patent 8349554 Needle array assembly and method for delivering therapeutic agents

Patent 8349554 was granted and assigned to Fred Hutchinson Cancer Research Center on January, 2013 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
8349554
January 8, 2013
‌
US Patent 8657786 Needle array assembly and method for delivering therapeutic agents

Patent 8657786 was granted and assigned to Fred Hutchinson Cancer Research Center on February, 2014 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
8657786
February 25, 2014
‌
US Patent 7122312 Methods for drug target screening

Patent 7122312 was granted and assigned to Fred Hutchinson Cancer Research Center on October, 2006 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7122312
October 17, 2006
‌
US Patent 7560117 Foamy virus mutant reverse transcriptase

Patent 7560117 was granted and assigned to Fred Hutchinson Cancer Research Center on July, 2009 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7560117
July 14, 2009
‌
US Patent 7771718 Soluble MIC polypeptides as markers for diagnosis, prognosis and treatment of cancer and autoimmune diseases or conditions

Patent 7771718 was granted and assigned to Fred Hutchinson Cancer Research Center on August, 2010 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7771718
August 10, 2010
‌
US Patent 10494434 Tagged chimeric effector molecules and receptors thereof

Patent 10494434 was granted and assigned to Fred Hutchinson Cancer Research Center on December, 2019 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10494434
December 3, 2019
‌
US Patent 7729863 Methods and materials for canine breed identification

Patent 7729863 was granted and assigned to Fred Hutchinson Cancer Research Center on June, 2010 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7729863
June 1, 2010
‌
US Patent 10538574 TCRS specific for minor histocompatibility (H) antigen HA-1 and uses thereof

Patent 10538574 was granted and assigned to Fred Hutchinson Cancer Research Center on January, 2020 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10538574
January 21, 2020
‌
US Patent 9987308 Method and compositions for cellular immunotherapy

Patent 9987308 was granted and assigned to Fred Hutchinson Cancer Research Center on June, 2018 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
9987308
June 5, 2018
‌
US Patent 7241804 Compositions and methods for modulating apoptosis in cells over-expressing Bcl-2 family member proteins

Patent 7241804 was granted and assigned to Fred Hutchinson Cancer Research Center on July, 2007 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7241804
July 10, 2007
‌
US Patent 10968275 Anti-ROR1 antibodies and uses thereof

Patent 10968275 was granted and assigned to Fred Hutchinson Cancer Research Center on April, 2021 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10968275
April 6, 2021
‌
US Patent 7173063 Topoisomerase poisons for the treatment of proliferative disorders

Patent 7173063 was granted and assigned to Fred Hutchinson Cancer Research Center on February, 2007 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7173063
February 6, 2007
‌
US Patent 7250505 Isolation and expression of a disabled protein gene mDab1 and methods

Patent 7250505 was granted and assigned to Fred Hutchinson Cancer Research Center on July, 2007 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7250505
July 31, 2007
‌
US Patent 9809813 Method of measuring adaptive immunity

Patent 9809813 was granted and assigned to Fred Hutchinson Cancer Research Center on November, 2017 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
9809813
November 7, 2017
‌
US Patent 10201570 Halogen treatment of heart attack and ischemic injury

Patent 10201570 was granted and assigned to Fred Hutchinson Cancer Research Center on February, 2019 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10201570
February 12, 2019
‌
US Patent 10188749 Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers

Patent 10188749 was granted and assigned to Fred Hutchinson Cancer Research Center on January, 2019 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10188749
January 29, 2019
‌
US Patent 10350245 Point-of-care and/or portable platform for gene therapy

Patent 10350245 was granted and assigned to Fred Hutchinson Cancer Research Center on July, 2019 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10350245
July 16, 2019
‌
US Patent 7666417 Methods and compositions for treating autoimmune diseases or conditions

Patent 7666417 was granted and assigned to Fred Hutchinson Cancer Research Center on February, 2010 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
7666417
February 23, 2010
‌
US Patent 6946266 Gene transfer in chicken bursal stem cells

Patent 6946266 was granted and assigned to Fred Hutchinson Cancer Research Center on September, 2005 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
6946266
September 20, 2005
‌
US Patent 9844563 Compositions, kits, and methods to induce acquired cytoresistance using stress protein inducers

Patent 9844563 was granted and assigned to Fred Hutchinson Cancer Research Center on December, 2017 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
9844563
December 19, 2017
‌
US Patent 11046766 Tagged chimeric effector molecules and receptors thereof

Patent 11046766 was granted and assigned to Fred Hutchinson Cancer Research Center on June, 2021 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
11046766
June 29, 2021
‌
US Patent 10156559 Lipocalin fusion partners

Patent 10156559 was granted and assigned to Fred Hutchinson Cancer Research Center on December, 2018 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
10156559
December 18, 2018
‌
US Patent 11078300 Circular tandem repeat proteins

Patent 11078300 was granted and assigned to Fred Hutchinson Cancer Research Center on August, 2021 by the United States Patent and Trademark Office.

Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
United States Patent and Trademark Office
United States Patent and Trademark Office
11078300
August 3, 2021
...
Results per page:
107 results
0 selected
107 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us